Stock price when the opinion was issued
Chart shows some pretty big swings. What is positive currently is that there is nice little upward trend, but is probably going to be in jeopardy based on the gravity affect. If it got below $2.70, he would say there is probably something wrong with the story. When you have a new industry like this, you will often get some rationalization, and in this new cycle, he expects it will happen much sooner. It’s really hard to tell which are the winners.
Contender, go by the wayside, or be acquired? Be careful, takeout premium is built in. If no takeout, there could be a blow up in the stock. Stuck in no man’s land, no R&D on pharmaceutical side, no export agreements. Tough for them to compete in exports and pharmaceuticals when the market price of wholesale marijuana reaches a plateau in a year or two.
This is going to be a massive growing sector. Legislation has not been tabled yet, and all these stocks have been running up on anticipation of the government’s task force reporting later this month. It is probably going to be about nothing, and doesn’t think the public is going to get access to it. You have to watch for when the legislation gets tabled, probably in 2017. Valuations have run up so much they have to be dangerous.